MENU
FDMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

4D Molecular Therapeutics (FDMT) Earnings Date & Reports

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more

A.I. Advisor
published Earnings

FDMT is expected to report earnings to fall 15.48% to -72 cents per share on August 11

4D Molecular Therapeutics FDMT Stock Earnings Reports
Q2'25
Est.
$-0.73
Q1'25
Est.
$-0.86
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.11
Q2'24
Beat
by $0.05
The last earnings report on May 08 showed earnings per share of -86 cents, meeting the estimate of -86 cents. With 552.77K shares outstanding, the current market capitalization sits at 260.81M.
View a ticker or compare two or three
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FDMT showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com